
Dolby Laboratories: quarterly results
Price
$60.30
November 16, 2026Market cap $5.8B
What Ploutos Investor adds for Dolby Laboratories
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 23% since Jul 30, 2026, when the 10-Q these figures come from was filed ($51.78 then, $63.61 on Nov 13, 2026). The figures date from before that move.10-Q
- The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.
Results, quarter by quarter
When the company put out each quarter's results (its 8-K, item 2.02), what they showed against the same quarter a year before, and how the stock moved on the first session after.
Next results
last Jul 30, 2026next Oct 29, 2026
An estimate from when it has reported before, which has been regular. The company announces the date itself.
The first session after results
±6.5%average move, either way
3 times upof the last 41 times down
Largest: +13.6% on Jul 31, 2026 (Q3 2026).
How the stock moved after each release
The close of the first session after the results against the close before them.
DLB that sessionS&P 500 the same day
Every release
Revenue and diluted EPS of the quarter reported, with the change against the same quarter a year before.
- Q3 2026Apr - Jun 2026Stock, next session+13.6%
- Q2 2026Jan - Mar 2026Stock, next session-10.4%
- Q1 2026Oct - Dec 2025Stock, next session+1.8%
- Q4 2025Jul - Sep 2025Stock, next session+0.1%
| Quarter | Released | Revenue | EPS | Stock, next session | S&P 500 | Filing |
|---|---|---|---|---|---|---|
| Q3 2026Apr - Jun 2026 | Jul 30, 2026after the close | $305M-3.3% | $0.30-37.5% | +13.6% | +0.7% | 8-K |
| Q2 2026Jan - Mar 2026 | Apr 30, 2026after the close | $396M+7.0% | $0.99+5.3% | -10.4% | +0.3% | 8-K |
| Q1 2026Oct - Dec 2025 | Jan 29, 2026after the close | $347M-2.9% | $0.55-21.4% | +1.8% | -0.4% | 8-K |
| Q4 2025Jul - Sep 2025 | Nov 18, 2025after the close | $307M+0.7% | $0.51-15.0% | +0.1% | +0.4% | 8-K |
Every release
DLB's results days and the share's move after each, from Q4 2009 to Q2 2025, 64 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 8 quarters.
and 59 more, back to Q4 2009
Times are the SEC's acceptance of the 8-K, in New York time: before 16:00 the market traded on it that day, after it the next day. A move on a results day has other causes too, and says nothing about the next one.
The full analysis
What do Dolby Laboratories's filings show?
The results say what Dolby Laboratories reported. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.